The DOH was already drafting guidelines on mixed-used COVID-19 vaccination, according to FDA.
The Food and Drug Administration (FDA) on Thursday said that the Department of Health (DOH) was already drafting guidelines on mixed-used COVID-19 vaccination.
FDA Director-General Eric Domingo said that the Department of Health was already drafting guidelines to allow a person to receive different COVID-19 vaccine brands for first and second doses.
Domingo said this following President Rodrigo Duterte’s request for China to recall its donation of Sinopharm COVID-19 vaccine, the same COVID-19 vaccine that he had himself vaccinated on Monday night.
Incidentally, Sinopharm has yet to secure emergency use authorization (EUA) from the country’s Food and Drug Administration (FDA) up to this time.
Addressing queries on what would happen to those who had been vaccinated with Sinopharm COVID-19 vaccine as first dose, Domingo said that the Department of Health was currently studying the possibility of mixed-use vaccination.
READ ALSO | President Duterte On Getting Sinopharm Jab: “I made it as a personal request”
In a Laging Handa briefing, Domingo said that the Department of Health was drafting guidelines on the interchangeability or mixing of COVID-19 vaccines in case the second dose of the same COVID-19 vaccine brand can’t be administered.
“Gumagawa ng guidelines ngayon ang DOH kung paano ‘yung interchangeability o mixing ng vaccines in case the second dose cannot be given na identical doon sa first dose,” Domingo said.
President Duterte was vaccinated last May 3 with the China-made COVID-19 vaccine, but soon after, President Duterte apologized for receiving a dose of the Sinopharm COVID-19 vaccine.
Earlier, Malacañang said that President Duterte was covered under the “compassionate use permit” issued by the Food and Drug Administration to the Presidential Security Group (PSG).
For more news and updates, you may feel free to visit this site more often. You may also visit Newspapers.ph via our official Facebook page and YouTube channel.